A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants

NCT05344989 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Tauopathies
Alzheimer Disease

Interventions

DRUG: APNmAb005
DRUG: Placebo

Sponsor

APRINOIA Therapeutics, LLC